Doxorubicin + BIBF 1120 in Patients for Ovarian Cancer

NCT01485874 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

11

Enrollment

OTHER

Sponsor class

Stopped Funding withdrawn due to drug unavailability

Conditions

Ovarian Cancer

Interventions

DRUG: Doxil (Pegylated Liposomal Doxorubicin)
DRUG: BIBF 1120

Sponsor

Hoosier Cancer Research Network

Collaborators

[object Object]